Clinical Trial Update: Epilepsy Self-Management for Spanish Speakers: HOBSCOTCH - ESPANOL [NA]

View source ↗

Summary

The clinical trial HOBSCOTCH - ESPANOL for epilepsy self-management in Spanish speakers has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Dysfunction
• Epilepsy
• Memory Disorders

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Epilepsy, Cognitive Dysfunction | NA | Status: WITHDRAWN